News & Stories
The Lifesaving Power of Genetic Testing — Ruth Gubernick’s Journey with Lynch Syndrome

“Genetic testing isn’t something to fear—it’s a powerful tool that can save lives.”
“In 2003, I was diagnosed with endometrial cancer and began follow-up care with Dr. Warshal at MD Anderson Cancer Center at Cooper. During one visit, he revisited my family history—something that hadn’t been emphasized in earlier consultations.”
“Drawing on insights from an educational session led by Dr. Grana about Lynch syndrome, he ordered a test that ultimately confirmed I carried a genetic variant of the condition. Lynch syndrome (formerly known as Hereditary Nonpolyposis Colon Cancer) increases the risk for several cancers, including colon and uterine—both of which appear in my family history.”
“My grandmother had died of endometrial cancer at 45, my mother had three primary cancers, and my sister had colon cancer before the age of 50. I was referred to Dr. Grana, who helped me understand the implications and develop a personalized screening plan.”
“Thanks to this program, I now undergo regular colonoscopies, upper endoscopies, pelvic ultrasounds, and urological exams, allowing for early detection and peace of mind.”
“The diagnosis gave me clarity and a sense of control I wish my mother had had. It also helped my children get screened and make informed decisions about their own health. Over time, I’ve also been treated for skin cancer and, more recently, breast cancer—though not related to Lynch syndrome.”
Despite the challenges, coordinated care through Cooper’s electronic health system has made managing everything easier.”
“The genetic testing program at MD Anderson at Cooper has been life-changing. I’m grateful for Dr. Grana’s leadership, early detection, and the chance to raise awareness about lynch syndrome.”
Funding from the William G. Rohrer Charitable Foundation has helped to develop both the clinical and laboratory components of the genetics program. This program also ensures that novel genetic testing approaches are available both to patients with cancer as well as unaffected individuals, such as family members.